Models of Alzheimer's Disease

Handbook of Models for Human Aging

Volumn , Issue , 2006, Pages 121-134

  LeVine, Harry ^a   Walker, Lary C ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857189643     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369391-4/50012-6     Document Type: Chapter

References (68)

1. F. Bian, R. Nath, G. Sobocinski, R.N. Booher, W.J. Lipinski, M.J. Callahan, et al. (2002) Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice. J Comp Neurol 446 257-266.
2. S. Boncristiano, M.E. Calhoun, V. Howard, L. Bondolfi, S.A. Kaeser, K.H. Wiederhold, et al. (2005) Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice. Neurobiol Aging 26 607-613.
3. D.R. Borchelt, T. Ratovitski, J. van Lare, M.K. Lee, V. Gonzales, N.A. Jenkins, et al. (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19 939-945.
4. D.R. Borchelt, G. Thinakaran, C.B. Eckman, M.K. Lee, F. Davenport, T. Ratovitsky, et al. (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17 1005-1013.
5. T. Bussiere, P.D. Friend, N. Sadeghi, B. Wicinski, G.I. Lin, C. Bouras, et al. (2002) Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease. Neuroscience 112 75-91.
6. M.J. Callahan, W.J. Lipinski, F. Bian, R.A. Durham, A. Pack and L.C. Walker (2001) Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. Am J Pathol 158 1173-1177.
7. M. Citron, D. Westaway, W. Xia, G. Carlson, T. Diehl, G. Levesque, et al. (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med 3 67-72.
8. M.A. Colle, J.-J. Hauw, F. Crespau, T. Uchihara, T. Akiyama, F. Checler, et al. (2000) Vascular and parenchymal Abeta deposition in the aging dog: Correlation with behavior. Neurobiol Aging 21 695-704.
9. J.L. Cummings (2004) Alzheimer's disease. N Engl J Med 351 56-67.
10. J. Davis, F. Xu, R. Deane, G. Romanov, M. Previti, K. Zeigler, et al. (2004) Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J Biol Chem 279 20296-20306.
11. R.B. DeMattos (2004) Apolipoprotein E Dose-dependent modulation of beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease. J Mol Neurosci 23 255-262.
12. B. Dermaut, S. Kumar-Singh, S. Engelborghs, J. Theuns, R. Rademakers, J. Saerens, et al. (2004) A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques. Ann Neurol 55 617-626.
13. M. Driscoll and B. Gerstbrein (2003) Dying for a cause: Invertebrate genetics takes on human neurodegeneration. Nat Rev Genet 4 181-194.
14. K. Duff, C. Eckman, C. Zehr, X. Yu, C.M. Prada, J. Perez-tur, et al. (1996) Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383 710-713.
15. P. Eikelenboom, C. Bate, W.A. Van Gool, J.J. Hoozemans, J.M. Rozemuller, R. Veerhuis and A. Williams (2002) Neuroinflammation in Alzheimer's disease and prion disease. Glia 40 232-239.
16. V. Fonte, V. Kapulkin, A. Taft, A. Fluet, D. Friedman and C.D. Link (2002) Interaction of intracellular beta amyloid peptide with chaperone proteins. Proc Natl Acad Sci USA 99 9439-9444.
17. J. Frackowiak, D.L. Miller, A. Potempska, T. Sukontasup and B. Mazur-Kolecka (2003) Secretion and accumulation of Abeta by brain vascular smooth muscle cells from AbetaPP-Swedish transgenic mice. J Neuropathol Exp Neurol 62 685-696.
18. J. Frackowiak, A. Potempska, H. LeVine, T. Haske, D. Dickson and B. Mazur-Kolecka (2005) Extracellular deposits of Abeta produced in cultures of Alzheimer disease brain vascular smooth muscle cells. J Neuropathol Exp Neurol 64 82-90.
19. S.A. Frautschy, F. Yang, L. Calderon and G.M. Cole (1996) Rodent models of Alzheimer's disease: Rat Abeta infusion approaches to amyloid deposits. Neurobiol Aging 17 311-321.
20. D. Games, D. Adams, R. Alessandrini, R. Barbour, P. Berthelette, C. Blackwell, et al. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373 523-527.
21. C. Geula, C.K. Wu, D. Saroff, A. Lorenzo, M. Yuan and B.A. Yankner (1998) Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat Med 4 827-831.
22. J. Gotz, F. Chen, J. van Dorpe and R.M. Nitsch (2001) Formation of neurofibrillary tangles in P3011 tau transgenic mice induced by Abeta 42 fibrils. Science 293 1491-1495.
23. J. Gotz, A. Schild, F. Hoerndli and L. Pennanen (2004) Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: Insight from transgenic mouse and tissue-culture models. Int J Dev Neurosci 22 453-465.
24. J. Hardy and D.J. Selkoe (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297 353-356.
25. J.-J. Hauw and C. Duyckaerts (2001) Alzheimer's Disease. S. Duckett, J.C. De La Torre, (Eds) Pathology of the Aging Human Nervous System New York: Oxford University Press 207-263.
26. M.C. Herzig, D.T. Winkler, P. Burgermeister, M. Pfeifer, E. Kohler, S.D. Schmidt, et al. (2004) Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 7 954-960.
27. P.R. Hof, E.P. Gilissen, C.C. Sherwood, H. Duan, P.W.H. Lee, B.N. Delman, et al. (2002) Comparative neuropathology of brain aging in primates. J.M. Erwin, P.R. Hof, (Eds) Aging in Nonhuman Primates Basel: Karger 130-154.
28. L. Holcomb, M.N. Gordon, E. McGowan, X. Yu, S. Benkovic, P. Jantzen, et al. (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4 97-100.
29. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, et al. (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274 99-102.
30. M. Jucker, L.C. Walker, L.J. Martin, C.A. Kitt, H.K. Kleinman, et al. (1992) Age-associated inclusions in normal and transgenic mouse brain. Science 255 1443-1445.
31. R. Kayed, E. Head, J.L. Thompson, T.M. McIntire, S.C. Milton, C.W. Cotman and C.G. Glabe (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 486-489.
32. D. Kirik, L. Annett, C. Burger, N. Muzyczka, R.J. Mandel and A. Bjorklund (2003) Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: A new primate model of Parkinson's disease. PNAS 100 2884-2889.
33. W.E. Klunk, B.J. Lopresti, M.L. Debnath, D.P. Holt, Y. Wang, G.-F. Huang, et al. (2004) Amyloid deposits in transgenic PS1/APP mice do not bind the amyloid PET tracer, PIB, in the same manner as human brain amyloid. Neurobiology of Aging 25 232.
34. P.N. Lacor, M.C. Buniel, L. Chang, S.J. Fernandez, Y. Gong, K.L. Viola, et al. (2004) Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci 24 10191-10200.
35. B.A. Lamb, K.A. Bardel, L.S. Kulnane, J.J. Anderson, G. Holtz, S.L. Wagner, et al. (1999) Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice. Nat Neurosci 2 695-697.
36. V.M. Lee, M. Goedert and J.Q. Trojanowski (2001) Neuro-degenerative tauopathies. Annu Rev Neurosci 24 1121-1159.
37. V.M. Lee, T.K. Kenyon and J.Q. Trojanowski (2005) Transgenic animal models of tauopathies. Biochim Biophys Acta 1739 251-259.
38. J. Lewis, D.W. Dickson, W.L. Lin, L. Chisholm, A. Corral, G. Jones, et al. (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293 1487-1491.
39. J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, et al. (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 25 402-405.
40. E. Marjaux, D. Hartmann and B. De Strooper (2004) Presenilins in memory, Alzheimer's disease, and therapy. Neuron 42 189-192.
41. M.P. Mattson (2002) Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease. J Neurovirol 8 539-550.
42. N.W. Milgram, E. Head, S.C. Zicker, C.J. Ikeda-Douglas, H.L. Murphey, B. Muggenburg, et al. (2005) Learning ability in aged beagle dogs is preserved by behavioral enrichment and dietary fortification: A two-year longitudinal study. Neurobiol Aging 26 77-90.
43. S. Oddo, L. Billings, J.P. Kesslak, D.H. Cribbs and F.M. LaFerla (2004) Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43 321-332.
44. S. Oddo, A. Caccamo, M. Kitazawa, B.P. Tseng and F.M. LaFerla (2003) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24 1063-1070.
45. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, R. Kayed, et al. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39 409-421.
46. A.L. Peel and D.E. Bredesen (2003) Activation of the cell stress kinase PKR in Alzheimer's disease and human amyloid precursor protein transgenic mice. Neurobiol Dis 14 52-62.
47. J. Poiner (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 17 525-530.
48. C.H. Rankin (2004) Invertebrate learning: What can't a worm learn? Curr Biol 14 R617-R618.
49. J.F. Reilly, D. Games, R.E. Rydel, S. Freedman, D. Schenk, W.G. Young, et al. (2003) Amyloid deposition in the hippocampus and entorhinal cortex: Quantitative analysis of a transgenic mouse model. Proc Natl Acad Sci USA 100 4837-4842.
50. T. Revesz, J. Ghiso, T. Lashley, G. Plant, A. Rostagno, B. Frangione and J.L. Holton (2003) Cerebral amyloid angiopathies: A pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 62 885-898.
51. J. Rohrbough, D.K. O'Dowd, R.A. Baines and K. Broadie (2003) Cellular bases of behavioral plasticity: Establishing and modifying synaptic circuits in the Drosophila genetic system. J Neurobiol 54 254-271.
52. B. Schonheit, R. Zarski and T.G. Ohm (2004) Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging 25 697-711.
53. C. Schwab, M. Hosokawa and P.L. McGeer (2004) Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease. Exp Neurol 188 52-64.
54. R. Siman, A.G. Reaume, M.J. Savage, S. Trusko, Y.G. Lin, R.W. Scott and D.G. Flood (2000) Presenilin-1 P264L knock-in mutation: Differential effects on abeta production, amyloid deposition, and neuronal vulnerability. J Neurosci 20 8717-8726.
55. C.T. Siwak, P.D. Tapp, E. Head, S.C. Zicker, H.L. Murphey, B.A. Muggenburg, et al. (2005) Chronic antioxidant and mitochondrial cofactor administration improves discrimination learning in aged but not young dogs. Prog Neuropsychopharmacol Biol Psychiatry 29 461-469.
56. C.M. Studzinski, J.A. Araujo and N.W. Milgram (2005) The canine model of human cognitive aging and dementia: Pharmacological validity of the model for assessment of human cognitive-enhancing drugs. Prog Neuropsychopharmacol Biol Psychiatry 29 489-498.
57. P.D. Tapp, C.T. Siwak, F.Q. Gao, J.Y. Chiou, S.E. Black, E. Head, et al. (2004) Frontal lobe volume, function, and beta-amyloid pathology in a canine model of aging. J Neurosci 24 8205-8213.
58. I. Tesseur, J. Van Dorpe, K. Spittaels, C. Van den Haute, D. Moechars and F. Van Leuven (2000) Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. Am J Pathol 156 951-964.
59. R. Torp, E. Head, N.W. Milgram, F. Hahn, O.P. Ottersen and C.W. Cotman (2000) Ultrastructural evidence of fibrillar beta-amyloid associated with neuronal membranes in behaviorally characterized aged dog brains. Neuroscience 96 495-506.
60. E. Vloeberghs, D. Van Dam, S. Engelborghs, G. Nagels, M. Staufenbiel and P.P. De Deyn (2004) Altered circadian locomotor activity in APP23 mice: A model for BPSD disturbances. Eur J Neurosci 20 2757-2766.
61. M.L. Voytko and G.P. Tinkler (2004) Cognitive function and its neural mechanisms in nonhuman primate models of aging, Alzheimer disease, and menopause. Front Biosci 9 1899-1914.
62. L.C. Walker, M.J. Callahan, F. Bian, R.A. Durham, A.E. Roher and W.J. Lipinski (2002) Exogenous induction of cerebral beta-amyloidosis in betaAPP-transgenic mice. Peptides 23 1241-1247.
63. L.C. Walker and L.C. Cork (1999) The neurobiology of aging in nonhuman primates. R.D. Terry, R. Katzman, K.L. Bick, S.S. Sisodia, (Eds) Alzheimer Disease Philadelphia: Lippincott Williams and Wilkins 233-243.
64. L.C. Walker, C.C. Ibegbu, C.W. Todd, H.L. Robinson, M. Jucker, H.R. LeVine and S. Gandy (2005) Emerging prospects for the disease-modifying treatment of Alzheimer's disease. Biochem Pharmacol 69 1001-1008.
65. M.L. Walker (1995) Menopause in female rhesus monkeys. Am J Primatology 35 59-71.
66. D.M. Walsh and D.J. Selkoe (2004) Oligomers on the brain: The emerging role of soluble protein aggregates in neurodegeneration. Protein Pept Lett 11 213-228.
67. J. Wegiel, H.M. Wisniewski, J. Dziewiatkowski, M. Tarnawski, J. Nowakowski, A. Dziewiatkowska and Z. Soltysiak (1995) The origin of amyloid in cerebral vessels of aged dogs. Brain Res 705 225-234.
68. T. Wisniewski, W.K. Dowjat, J.D. Buxbaum, O. Khorkova, S. Efthimiopoulos, J. Kulczycki, et al. (1998) A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years. Neuroreport 9 217-221.